Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06295471 · ClinicalTrials.gov registry record · NA

A Comparative Clinical Study to Assess Pain Score and Wound Healing Following Fractional Ablation With a DFG Laser and CO2 Laser

A NA study of Healthy, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT06295471: Recruiting NA study of Healthy, sponsored by Massachusetts General Hospital.

NCT06295471 is a NA study of Healthy that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 23 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06295471, a NA study of Healthy, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

This research study aims assess whether the Difference Frequency Generation (DFG) laser could be a better alternative to the CO2 laser in terms of reduced side effects and patient downtime.

Conditions Studied

Interventions

  • DEVICE DFG Laser
  • DEVICE CO2 Laser
  • DEVICE Optical coherence tomography (OCT)

Study Locations (1)

Massachusetts

  • MGH Clinical Unit for Research Trials & Outcomes in Skin - Boston

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2024-10-16
Est. Completion 2026-03
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06295471

The ClinicalTrials.gov registry entry for NCT06295471 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which DFG Laser is the first listed.

NCT06295471 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06295471 about?

NCT06295471 is a clinical study titled "A Comparative Clinical Study to Assess Pain Score and Wound Healing Following Fractional Ablation With a DFG Laser and CO2 Laser". This research study aims assess whether the Difference Frequency Generation (DFG) laser could be a better alternative to the CO2 laser in terms of reduced side effects and patient downtime.

What is the current status of trial NCT06295471?

This trial is currently recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2024-10-16. Estimated completion is 2026-03.

What conditions does trial NCT06295471 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06295471?

The interventions under investigation include: DFG Laser (DEVICE), CO2 Laser (DEVICE), Optical coherence tomography (OCT) (DEVICE).

Who is sponsoring clinical trial NCT06295471?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06295471 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.